Psychedelics Policy Newsletters
The Psychedelics Policy Newsletter examines the latest psychedelics policy news and developments.
If you would like to receive the Psychedelics Policy Newsletter via email, please enter your email address below.
Previous issues of this newsletter are below and Reason Foundation's drug-related research is available here.
-
Psychedelics Policy Newsletter: MDMA rejection, advocating for lower state fees in Colorado, and more
Plus: A profile of ibogaine advocate Bryan Hubbard, the Drug Enforcement Administration head worries about ketamine, and more.
-
Psychedelics Policy Newsletter: A glimpse into Colorado after psychedelics legalization, a gathering of conservative legislators, and more
Plus: Food and Drug Administration approval of MDMA is tentative, the psychedelic origins of Whole Foods, and more.
-
Psychedelics Policy Newsletter: Massachusetts ballot initiative would foster access, state legislature momentum stalls, and more
Plus: The National Institute of Health awards money for addiction research, a Michigan poll signals interest in psychedelics, and more.
-
Psychedelics Policy Newsletter: A retail system model, ibogaine research, and legalization updates
A model that would reduce costs and increase consumer access to psychedelics by streamlining the overall regulatory burden.
-
Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more
Plus: State news roundup and the defense spending bill calls for research on using psychedelics to treat PTSD in military members, and more.
-
Psychedelics Policy Newsletter: California’s steps after bill vetoed, Kentucky ibogaine funds, and more
Plus: New Drug Policy Handbook, the latest on implementing Colorado's legalization, and more.
